Drawing for SARMONT

USPTO serial 85293918

SARMONT

Reviewed by CopyMark Law Group

Reg. 4056220Status 710
Filing date
Status date
Registration date
Nov 15, 2011
Examiner
SAITO, KIM
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SARMONT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Smith

MATTHEW J. SMITH POLSINELLI SHUGHART PC100 S 4TH ST STE 1000SAINT LOUIS, MO 63102-1825UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Contract scientific and technical research for pharmaceuticals, biotech products and chemicals; pharmaceutical drug discovery, development and research in the fields of pharmaceuticals, biotech products, chemicals; clinical trials for drugs; consumer testing services for ensuring the safety and efficacy of drugs; research services in the areas of chemistry, pharmacology, medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry, and computational chemistry; Scientific research and development services, namely, laboratory research and monitoring of clinical trials for diagnostic tests for drug screening, instruments for drug screening, and pharmaceuticals; Scientific and technological services for drug development and discovery; Scientific and technological services to identify novel drug targets and research and design relating thereto, and scientific and technological services to characterize off-target activities of candidate and established drugs to understand the basis for their efficacy and toxicity and research and design relating thereto; Chemical and pharmaceutical research and development for others; laboratory research in the field of analytical and medicinal chemistrySECTION 8 - CANCELLEDJan 1, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2018C8..CANCELLED SEC. 8 (6-YR)—
Nov 15, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 15, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2011DOCKASSIGNED TO EXAMINER—
Apr 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance